News Article
Cabozantinib potential option to treat differentiated thyroid cancer
14 Feb 2018

According to results that will be presented at the 2018 Multidisciplinary Head and Neck Cancers Symposium in Arizona this Friday, tumours treated with the drug shrunk in 97% of patients.

Science Daily